Table 3.
Clinical and pathological characteristics of Helicobacter pylori infection‐negative gastric cancer
Mucosal atrophy by pepsinogen (PG) method | n | Sex male/female | Pathology % Well/poor | Stage % Early/advanced |
---|---|---|---|---|
No Atrophy † | 15 | 10/5 | 33/67 | 37/63 |
Mild and moderate atrophy ‡ | 64 | 40/24 | 53/47 | 38/62 |
Severe Atrophy § | 27 | 16/11 | 44/56 | 40/60 |
Total | 106 | 66/40 | 46/54 | 38/62 |
No atrophy (–), PG I > 70 & PG I/II > 3.0;
‡ Mild and moderate atrophy: exclude no atrophy and severe atrophy cases;
Severe atrophy, PG I ≤ 30 & PG I/II ≤ 2.0.